Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review-Reference-Cited by-同舟云学术

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

Published:2015-10-22 Issue:10 Volume:10 Page:e0140717
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Trojan Jörg,Mineur Laurent,Tomášek Jiří,Rouleau Etienne,Fabian Pavel,de Maglio Giovanna,García-Alfonso Pilar,Aprile Giuseppe,Taylor Aliki,Kafatos George,Downey Gerald,Terwey Jan-Henrik,van Krieken J. Han

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;C Bokemeyer;J Clin Oncol,2009

2. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;D Cunningham;N Engl J Med,2004

3. Cetuximab for the treatment of colorectal cancer;DJ Jonker;N Engl J Med,2007

4. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer;AF Sobrero;J Clin Oncol,2008

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;E Van Cutsem;N Engl J Med,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in Monoclonal antibodies based formulation used in the management of CRC;J PHARM NEGAT RESULT;2022

2. An evaluation of RAS testing among metastatic colorectal cancer patients in the USA;Future Oncology;2021-05

3. Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database;Future Oncology;2021-04

4. PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer;PLOS ONE;2020-12-21

5. Guideline-recommended incorporation of biomarker testing results in metastatic colorectal cancer therapy;Personalized Medicine;2020-05-01